Investigating the Therapeutic Mechanism of Ginkgo Biloba Extract in Alzheimer’s Disease via Integrated Network Pharmacology and Molecular Docking
Die Pharmazie · 23.07.2026 · 81 (7)
DOI: 10.31083/pharmazie51748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Pharmazie, online erschienen am 23.07.2026. Verfasst von Yipei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Henan Medical Key Laboratory of Neurodegenerative Diseases, Henan Medical College, 451191 Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Ginkgolides, Ginkgo biloba, Alzheimer Disease, Plant Extracts. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Project in Henan Province.
Themen: Demenz
Abstract (Originalsprache)
Objective:This study aimed to investigate the mechanisms through which ginkgolides in Ginkgo biloba extract (GBE) may protect against Alzheimer’s disease (AD).Methods:Candidate ginkgolide constituents and their putative targets were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and SwissTargetPrediction. AD-associated genes were retrieved from OMIM and GeneCards. Overlapping targets were used to construct component–target–disease and protein–protein interaction (PPI) networks for hub target screening. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using DAVID. AutoDock Vina was used for molecular docking, and molecular dynamics simulations were conducted to evaluate ligand–target stability. The predicted mechanisms were further examined in APP/PS1 mice and Aβ1-42-treated HT22 cells.Results:A total of 27 active ginkgolide-related constituents and 336 intersecting targets were identified. Ginkgolides B and M were identified as the major active compounds, whereas MAPK3, HIF-1α, and AKT1 emerged as important targets. Enrichment analysis indicated a close association with the PI3K–Akt pathway. Docking analysis showed that ginkgolides B and M bound strongly to MAPK3 and HIF-1α with binding energies ranging from –9.34 to –8.41 kcal/mol. Molecular dynamics simulations supported the stable formation of these complexes. In vivo and in vitro experiments showed that ginkgolides B and M alleviated synaptic protein damage, decreased HIF-1α expression, and improved cognitive deficits.Conclusions:Ginkgolides B and M may contribute to anti-AD effects in experimental models, partly through modulation of HIF-1α-related stress responses and PI3K–Akt-associated survival pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Medical Key Laboratory of Neurodegenerative Diseases, Henan Medical College, 451191 Zhengzhou, Henan, China.
- Department of Pathophysiology, School of Basic Medical Sciences, Henan Medical College, 451191 Zhengzhou, Henan, China.
- Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, 214122 Wuxi, Jiangsu, China.
- Clinical Medicine Science and Education Center, Faculty of Medicine, Huanghe Science and Technology College, 450061 Zhengzhou, Henan, China.
Förderung
- Scientific and Technological Project in Henan Province
Zitieren
APA
Li, Y., Gong, J., Yang, L., Jin, L., Peng, R., Wang, F., & Wang, L. (2026). Investigating the Therapeutic Mechanism of Ginkgo Biloba Extract in Alzheimer’s Disease via Integrated Network Pharmacology and Molecular Docking. Die Pharmazie, 81(7). https://doi.org/10.31083/pharmazie51748
Vancouver
Li Y, Gong J, Yang L, Jin L, Peng R, Wang F, et al. Investigating the Therapeutic Mechanism of Ginkgo Biloba Extract in Alzheimer’s Disease via Integrated Network Pharmacology and Molecular Docking. Die Pharmazie. 2026;81(7). doi:10.31083/pharmazie51748
BibTeX
@article{Li2026,
author = {Li, Yipei and Gong, Juan and Yang, Liu and Jin, Li and Peng, Ruirui and Wang, Fang and Wang, Li},
title = {Investigating the Therapeutic Mechanism of Ginkgo Biloba Extract in Alzheimer’s Disease via Integrated Network Pharmacology and Molecular Docking},
journal = {Die Pharmazie},
year = {2026},
volume = {81},
number = {7},
doi = {10.31083/pharmazie51748}
}
EUVIMED